Transaction · 0001493152-26-040513

SVF Pauling (Cayman) Ltd

SVF Pauling (Cayman) Ltd, 10%, reported an open-market or private sale at Relay Therapeutics, Inc. involving 6000000.000000 shares for an estimated $116400000.00. Reported holdings after the transaction were 21904963.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code S10%
RLAYRelay Therapeutics, Inc.
Filing timeAug 28
Trade dateAug 25, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

RLAY price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RLAY since 2026-08-28Filed 6 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001493152-26-040513
Common Stock
Transaction date
Aug 25, 2026
Filed Aug 28, 2026, 01:01 PM · 3d delay
Shares
6.00M sh
$1.94k per share
Estimated value
-$11.6B
Computed from shares × price
Holdings after
21.9M sh
Indirect · See footnote

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Large Holdings Reduction Large Sale
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector No10% YesOther No
Footnotes & amended
  1. F1

    Securities held of record by SVF Pauling (Cayman) Limited, a wholly owned subsidiary of SoftBank Vision Fund (AIV M2) L.P. ("AIV M2"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointe…

Original filing · 0001493152-26-040513
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RLAY